[go: up one dir, main page]

MX2007000224A - Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos. - Google Patents

Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos.

Info

Publication number
MX2007000224A
MX2007000224A MX2007000224A MX2007000224A MX2007000224A MX 2007000224 A MX2007000224 A MX 2007000224A MX 2007000224 A MX2007000224 A MX 2007000224A MX 2007000224 A MX2007000224 A MX 2007000224A MX 2007000224 A MX2007000224 A MX 2007000224A
Authority
MX
Mexico
Prior art keywords
dicyano
nausea
vomiting
thio
phenyl
Prior art date
Application number
MX2007000224A
Other languages
English (en)
Inventor
Thomas Kramer
Thomas Krahn
Ulrich Rosentreter
Nicole Diedrichs
Wolfgang Thielemann
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of MX2007000224A publication Critical patent/MX2007000224A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

La presente invencion se refiere al uso de 2-tio-3, 5-diciano-4-fenil-6-aminopiridinas sustituidas de formula (I) para la preparacion de un medicamento para la profilaxis y/o tratamiento de nauseas y vomitos.
MX2007000224A 2004-07-06 2005-06-23 Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos. MX2007000224A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004032651A DE102004032651A1 (de) 2004-07-06 2004-07-06 Verwendung von substituierten 2-Thio-3,5-dicyano-4-phenyl-6-aminopyriden bei der Behandlung von Übelkeit und Erbrechen
PCT/EP2005/006779 WO2006002823A1 (de) 2004-07-06 2005-06-23 Verwendung von substituierten 2-thio-3,5-dicyano-4-phenyl-6-aminopyridinen bei der behandlung von übelkeit und erbrechen

Publications (1)

Publication Number Publication Date
MX2007000224A true MX2007000224A (es) 2007-06-15

Family

ID=34970906

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007000224A MX2007000224A (es) 2004-07-06 2005-06-23 Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos.

Country Status (18)

Country Link
US (1) US7709504B2 (es)
EP (1) EP1765343B1 (es)
JP (1) JP2008505139A (es)
KR (1) KR20070041561A (es)
CN (1) CN101014342A (es)
AT (1) ATE446753T1 (es)
AU (1) AU2005259506A1 (es)
BR (1) BRPI0513149A (es)
CA (1) CA2572990A1 (es)
DE (2) DE102004032651A1 (es)
EC (1) ECSP077130A (es)
ES (1) ES2333805T3 (es)
IL (1) IL180551A0 (es)
MA (1) MA28707B1 (es)
MX (1) MX2007000224A (es)
NO (1) NO20070608L (es)
RU (1) RU2007104234A (es)
WO (1) WO2006002823A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10110747A1 (de) * 2001-03-07 2002-09-12 Bayer Ag Substituierte 2,6-Diamino-3,5-dicyano-4-aryl-pyridine und ihre Verwendung
DE102004042607A1 (de) * 2004-09-03 2006-03-09 Bayer Healthcare Ag Substituierte Phenylaminothiazole und ihre Verwendung
DE102006042143A1 (de) * 2006-09-08 2008-03-27 Bayer Healthcare Aktiengesellschaft Neue substituierte Bipyridin-Derivate und ihre Verwendung
DE102006056739A1 (de) * 2006-12-01 2008-06-05 Bayer Healthcare Ag Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung
DE102006056740A1 (de) * 2006-12-01 2008-06-05 Bayer Healthcare Ag Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung
DE102007035367A1 (de) 2007-07-27 2009-01-29 Bayer Healthcare Ag Substituierte Aryloxazole und ihre Verwendung
DE102007036076A1 (de) 2007-08-01 2009-02-05 Bayer Healthcare Aktiengesellschaft Dipeptoid-Produgs und ihre Verwendung
DE102007061763A1 (de) * 2007-12-20 2009-06-25 Bayer Healthcare Ag Substituierte azabicyclische Verbindungen und ihre Verwendung
DE102007061764A1 (de) * 2007-12-20 2009-06-25 Bayer Healthcare Ag Anellierte Cyanopyridine und ihre Verwendung
DE102008013587A1 (de) * 2008-03-11 2009-09-17 Bayer Schering Pharma Aktiengesellschaft Heteroaryl-substituierte Dicyanopyridine und ihre Verwendung
CA2726020C (en) * 2008-05-29 2016-08-16 Bayer Schering Pharma Aktiengesellschaft 2-alkoxy-substituted dicyanopyridines and use thereof
DE102008062567A1 (de) 2008-12-16 2010-06-17 Bayer Schering Pharma Aktiengesellschaft Dipeptoid-Prodrugs und ihre Verwendung
DE102009006602A1 (de) * 2009-01-29 2010-08-05 Bayer Schering Pharma Aktiengesellschaft Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs
DE102010030688A1 (de) 2010-06-30 2012-01-05 Bayer Schering Pharma Aktiengesellschaft Substituierte Dicyanopyridine und ihre Verwendung
US20120058983A1 (en) 2010-09-02 2012-03-08 Bayer Pharma Aktiengesellschaft Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension
CR20200464A (es) 2018-03-08 2021-04-14 Incyte Corp Compuestos diólicos de aminopirazina como inhibidores de pi3k-y
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors
WO2025038781A1 (en) * 2023-08-15 2025-02-20 Lucy Therapeutics, Inc. Adenosine ligands for the treatment of neurological disorders or chronic heart failure

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0105469D0 (en) * 2001-03-06 2001-04-25 Glaxo Group Ltd Medicaments
DE10115922A1 (de) * 2001-03-30 2002-10-10 Bayer Ag Cyclisch substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
DE10134481A1 (de) 2001-07-16 2003-01-30 Bayer Ag Substituierte 2-Thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre Verwendung
DE10238113A1 (de) * 2001-12-11 2003-06-18 Bayer Ag Substituierte 2-Thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre Verwendung
PL372145A1 (en) * 2002-02-19 2005-07-11 Cv Therapeutics, Inc. Partial and full agonists of a sb 1 /sb adenosine receptors

Also Published As

Publication number Publication date
ES2333805T3 (es) 2010-03-01
RU2007104234A (ru) 2008-08-20
CA2572990A1 (en) 2006-01-12
DE102004032651A1 (de) 2006-02-16
JP2008505139A (ja) 2008-02-21
ATE446753T1 (de) 2009-11-15
KR20070041561A (ko) 2007-04-18
NO20070608L (no) 2007-02-01
IL180551A0 (en) 2008-03-20
EP1765343A1 (de) 2007-03-28
WO2006002823A1 (de) 2006-01-12
DE502005008416D1 (de) 2009-12-10
EP1765343B1 (de) 2009-10-28
US7709504B2 (en) 2010-05-04
MA28707B1 (fr) 2007-06-01
BRPI0513149A (pt) 2008-04-29
AU2005259506A1 (en) 2006-01-12
CN101014342A (zh) 2007-08-08
ECSP077130A (es) 2007-02-28
US20080249133A1 (en) 2008-10-09

Similar Documents

Publication Publication Date Title
MX2007000224A (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos.
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
TW200740776A (en) N-phenylbenzotriazolyl c-kit inhibitors
CY1110209T1 (el) Υποκατεστημενες ενωσεις βενζο(d)ισοξαζολ-3-υλ-αμινης σαν αναλγητικα
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
UA92355C2 (en) urn:schemas-microsoft-com:office:smarttags2,4-DIAMINO-PYRIMIDINES USED AS AURORAINHIBITORS
TW200806300A (en) New therapeutic combinations for the treatment of depression
MY153921A (en) Aminopyrazole derivatives
MX2007003108A (es) Compuestos imidazo-3-il-amina sustituidos y biciclicos.
IL173062A0 (en) Substituted 2-aminotetralin for the treatment of depression
PL1891004T3 (pl) Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych
TW200722081A (en) New therapeutic combinations for the treatment or prevention of depression
TW200633992A (en) Biaryloxymethylarenecarboxylic acids
TW200740429A (en) Methods and dosage forms for reducing side effects of carbamate compounds
UA96969C2 (en) Acylaminopyrazoles as fgfr inhibitors
TW200700064A (en) Novel compounds
TW200700071A (en) Novel use
PL1888514T3 (pl) Sole podstawionych estrów kwasu alofanowego i ich zastosowanie w środkach leczniczych
MX2007010143A (es) Formas cristalinas de intermedio de linezolid.
IL194353A0 (en) Lysobactin amides
UA94080C2 (ru) Ациклически-замещенные производные фуропиримидина и их применение для лечения сердечно-сосудистых заболеваний
UA94781C2 (ru) Применение йота-каррагенана для профилактики или терапевтического лечения риновирусной инфекции
MX2007006042A (es) Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion, composiciones que las contienen y utilizacion.
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents

Legal Events

Date Code Title Description
FA Abandonment or withdrawal